{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:50:16Z","timestamp":1785322216413,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The diagnosis of acute central retinal artery occlusion (CRAO) is commonly delayed in emergency departments (ED) where ophthalmologists are rarely available for immediate consultation. Thrombolysis is sometimes given empirically for presumed CRAO without confirmation of the diagnosis with ocular funduscopic examination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We describe one case of severe intraocular hemorrhage following intravenous thrombolysis for a retinal detachment misdiagnosed as a CRAO, and two cases of worsening intraocular hemorrhage following intravenous thrombolysis for misdiagnosed CRAO, and review the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 4 cases in the literature were thrombolysis given for RAO resulted in ocular hemorrhage. We identified 12 additional cases where thrombolysis given for any indication resulted in intraocular hemorrhage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Ocular hemorrhage is a rare but potentially devastating complication of thrombolysis in patients with underlying retinal disorders other than CRAO. Thrombolysis should never be given for acute vision loss without a funduscopic examination or ocular imaging confirming the diagnosis of CRAO.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1631546","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:14:22Z","timestamp":1755663262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Intraocular hemorrhage in patients misdiagnosed with central retinal artery occlusion treated with thrombolysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Daniel V.","family":"Adamkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Y.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Arepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ferenchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"B\u00e9nard-S\u00e9guin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Biousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ophtha.2024.12.024","article-title":"Retinal and ophthalmic artery occlusions preferred practice pattern","volume":"127","author":"Kovach","year":"2020","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/STR.0000000000000366","article-title":"Management of central retinal artery occlusion: a scientific statement from the American Heart Association","volume":"52","author":"Mac Grory","year":"2021","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/WNO.0000000000001027","article-title":"Thrombolysis for central retinal artery occlusion in 2020: time is vision!","volume":"40","author":"Dumitrascu","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.oret.2023.12.007","article-title":"Central retinal artery occlusion: visual outcomes from a large northern California cohort","volume":"8","author":"Shah","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ophtha.2023.11.031","article-title":"A remote consult retinal artery occlusion diagnostic protocol","volume":"131","author":"Lema","year":"2024","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"107895","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107895","article-title":"Eye stroke protocol in the emergency department","volume":"33","author":"B\u00e9nard-S\u00e9guin","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1089\/tmj.2022.0286","article-title":"Telemedicine for acute monocular visual loss: a retrospective large telestroke network experience","volume":"29","author":"Dumitrascu","year":"2023","journal-title":"Telemed J E Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"102204","DOI":"10.1016\/j.ajoc.2024.102204","article-title":"A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion","volume":"36","author":"Gilbert","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.survophthal.2024.09.012","article-title":"Breaking the barriers: methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department","volume":"70","author":"Berman","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/tmj.2024.0435","article-title":"Remote diagnosis of retinal detachment in an emergency department using nonmydriatic hybrid ocular imaging","volume":"31","author":"Shanmugam","year":"2025","journal-title":"Telemed J E Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jemermed.2020.08.003","article-title":"A narrative review of common uses of ophthalmic ultrasound in emergency medicine","volume":"60","author":"Skidmore","year":"2021","journal-title":"J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jemermed.2012.11.079","article-title":"Pitfalls in the use of ocular ultrasound for evaluation of acute vision loss","volume":"44","author":"Schott","year":"2013","journal-title":"J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1179\/174313209X444008","article-title":"Intra-arterial thrombolysis for acute central retinal artery occlusion","volume":"31","author":"Zhang","year":"2009","journal-title":"Neurol Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/medicina57090963","article-title":"Complications of intra-arterial tPA for iatrogenic branch retinal artery occlusion: a case report through multimodal imaging and literature review","volume":"57","author":"Dalzotto","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/23969873231185895","article-title":"Safety and effectiveness of IV thrombolysis in retinal artery occlusion: a multicenter retrospective cohort study","volume":"8","author":"Baumgartner","year":"2023","journal-title":"Eur Stroke J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/bjo.74.7.447-a","article-title":"Total hyphema following streptokinase administration eight days after cataract extraction","volume":"74","author":"Cahane","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/0002-8703(91)90164-D","article-title":"Thrombolytic therapy for acute myocardial infarction following recent cataract surgery","volume":"121","author":"Glikson","year":"1991","journal-title":"Am Heart J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0002-8703(95)90371-2","article-title":"Bilateral vitreous hemorrhages as a consequence of thrombolytic therapy successfully treated with vitrectomy in a patient without diabetes","volume":"130","author":"Grekos","year":"1995","journal-title":"Am Heart J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/s0735-1097(97)00394-x","article-title":"Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global utilization of streptokinase and t-PA for occluded coronary arteries","volume":"30","author":"Mahaffey","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0161-6420(98)93023-8","article-title":"Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents","volume":"105","author":"Chorich","year":"1998","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1034\/j.1600-0420.2002.800522_1.x","article-title":"A case of intraocular haemorrhage secondary to thrombolytic therapy","volume":"80","author":"Berry","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/112067210301300117","article-title":"Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative macular degeneration","volume":"13","author":"Djalilian","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0140-6736(05)70198-7","article-title":"Intraocular haemorrhage after thrombolysis","volume":"365","author":"Kaba","year":"2005","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4103\/1947-2714.139310","article-title":"Endocapsular hematoma: a rare form of ocular hemorrhage after thrombolysis with streptokinase","volume":"6","author":"Dhawan","year":"2014","journal-title":"N Am J Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e669","DOI":"10.1016\/j.chest.2021.03.074","article-title":"Sudden unilateral vision loss in a patient who received intravenous thrombolytic therapy","volume":"160","author":"Shah","year":"2021","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fneur.2012.00071","article-title":"Vitreo-retinal hemorrhage after thrombolysis in a patient with acute ischemic stroke: a case report","volume":"3","author":"Hormese","year":"2012","journal-title":"Front Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/WNL.82.10_supplement.P4.227","article-title":"Vitreous hemorrhage as a complication of IV-tPA therapy in a patient with acute stroke","volume":"82","author":"Shah","year":"2014","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","article-title":"Effects of alteplase beyond 3 h after stroke in the Echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial","volume":"7","author":"Davis","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S1474-4422(15)70017-7","article-title":"Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study","volume":"14","author":"Huang","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial","volume":"16","author":"Logallo","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset","volume":"379","author":"Thomalla","year":"2018","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1747493019840938","article-title":"Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection","volume":"14","author":"Ringleb","year":"2019","journal-title":"Int J Stroke"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/svn-2021-000978","article-title":"Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study","volume":"7","author":"Li","year":"2022","journal-title":"Stroke Vasc Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0140-6736(22)02600-9","article-title":"Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial","volume":"401","author":"Wang","year":"2023","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/jama.2024.14721","article-title":"Tenecteplase vs alteplase for patients with acute ischemic stroke: the ORIGINAL randomized clinical trial","volume":"332","author":"Meng","year":"2024","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa2402980","article-title":"Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy","volume":"391","author":"Xiong","year":"2024","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/svn-2023-003035","article-title":"Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial","volume":"9","author":"Li","year":"2024","journal-title":"Stroke Vasc Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1397751","DOI":"10.3389\/fneur.2024.1397751","article-title":"Central retinal artery occlusion or retinal stroke: a neurosonologist's perspective","volume":"15","author":"Taroza","year":"2024","journal-title":"Front Neurol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1212\/WNL.0000000000004868","article-title":"Ophthalmoscopy in the 21st century: the 2017 H. Houston Merritt lecture","volume":"90","author":"Biousse","year":"2018","journal-title":"Neurology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1212\/WNL.0000000000200969","article-title":"Improving the telemedicine evaluation of patients with acute vision loss: a call to eyes","volume":"99","author":"English","year":"2022","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1631546\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:14:23Z","timestamp":1755663263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1631546\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":47,"alternative-id":["10.3389\/fneur.2025.1631546"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1631546","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"article-number":"1631546"}}